Statera BioPharma Inc
STAB
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.14K
Close$
Share Statistics
| Market cap | $7,142.00 |
|---|---|
| Enterprise Value | $7.29 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-4.97 |
| Beta | -4.78 |
| Outstanding Shares | 50,234,111 |
Return
| Return on Equity | 1018.79% |
|---|---|
| Return on Assets | -818.39% |
| Return on Invested Capital | 325.79% |
Valuation & Multiples
| P/E Ratio | 0 |
|---|---|
| PEG | 0 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 1.98 |
| Enterprise Value to EBIT | -0.24 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 1.07 |
| Debt to Equity | -0.76 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Statera BioPharma Inc
4 employeesStatera Biopharma is a clinical-stage biopharmaceutical company developing novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses and cancers based on a proprietary platform designed to rebalance the body’s immu...